Literature DB >> 25635870

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients.

.   

Abstract

Entities:  

Year:  2015        PMID: 25635870      PMCID: PMC4312032          DOI: 10.1371/journal.pone.0117673

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There are errors in the Funding section. The correct funding information is as follows: This work was funded by the Muscular Dystrophy Association of USA (MDA), the Fight-MG grant of the FP7 EC program, the Association Francaise contre les Myopathies (AFM), the European Commission (Contract No 242210), the Greek GSRT (program “Aristeia”), FP-7 Research potential Program/Regpot SEEDRUG of University of Patras (Grant number: EU FP7 REGPOT CT-2011-285950) and by the Greek national funds through the Operational Program “Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  1 in total

1.  Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.

Authors:  Gregory Kordas; George Lagoumintzis; Sotirios Sideris; Konstantinos Poulas; Socrates J Tzartos
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.